Investigating the role of miRNA-98 and miRNA-214 in chemoresistance of HepG2/Dox cells: studying their effects on predicted ABC transporters targets
- 1 February 2018
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 27 (2) , 531-537
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Development Fund (EG) (4361)
This publication has 24 references indexed in Scilit:
- MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)Cancer Letters, 2013
- MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinomaInternational Journal of Oncology, 2013
- Identification of microRNA-98 as a Therapeutic Target Inhibiting Prostate Cancer Growth and a Biomarker Induced by Vitamin DJournal of Biological Chemistry, 2013
- Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft modelsCancer Letters, 2013
- MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinomaMolecular Cancer, 2012
- Shielding the messenger (RNA): microRNA-based anticancer therapiesPharmacology & Therapeutics, 2011
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour typesEuropean Journal of Cancer, 2010
- Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific TargetJournal of Biological Chemistry, 2008
- MicroRNA expression profiles for the NCI-60 cancer cell panelMolecular Cancer Therapeutics, 2007
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976